Treatment of hemophilia.
Meili
E O
EO
Gerinnungslabor, Universitätsspital Zürich, Switzerland.
D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D005260:Female; D006580:Genetic Carrier Screening; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission; D006467:Hemophilia A / Q000235:genetics / Q000517:prevention & control / Q000628:therapy*; D006470:Hemorrhage / Q000235:genetics / Q000517:prevention & control / Q000628:therapy; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011296:Prenatal Diagnosis; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005169:Factor VIII; D005164:Factor IX; D003894:Deamino Arginine Vasopressin